Aandelen in “Diensten aan de gezondheidssector”

Aandeel Datum Koers Evolutie
vlag Physiomics 31/10 0,425 GBX
0,00% 		0,00%
vlag Protalix BioTherapeutics Inc. 31/10 2,370 USD
+4,87% 		+4,87%

Nieuws over “Diensten aan de gezondheidssector”

28/10 · Labcorp Announces 2025 Third Quarter Results · Persbericht

28/10 · Labcorp Announces 2025 Third Quarter Results · Persbericht

27/10 · New Study Demonstrates Accuracy of Two Quest AD-Detect® Tests for Alzheimer's Disease Diagnosis · Persbericht

23/10 · Cegedim: like-for-like revenue growth of 2.1% over 9 months is on target · Persbericht

23/10 · Labcorp to Offer First FDA-Cleared Blood Test to Rule out Alzheimer's-Related Amyloid Pathology in Primary Care Settings · Persbericht

21/10 · Quest Diagnostics Reports Third Quarter 2025 Financial Results; Raises Guidance for Full Year 2025 · Persbericht

15/10 · Mercy Earns National Honor for Excellence in Patient Experience · Persbericht

10/10 · Cegedim: Release of its 2025 Interim Financial Report · Persbericht

8/10 · Labcorp Declares Quarterly Dividend · Persbericht

8/10 · Cegedim: Stacks selected to coordinate a new electronic medical record in the Balearic Islands · Persbericht

6/10 · Cegedim: DISCLOSURE OF SHARE CAPITAL AND VOTING RIGHTS · Persbericht

30/09 · Labcorp Announces Collaboration with Roche to Advance Digital Pathology Capabilities · Persbericht

26/09 · Equasens: 2025 half-year results · Persbericht

25/09 · Labcorp to Announce Third Quarter Financial Results on October 28, 2025 · Persbericht

25/09 · Cegedim’s profitability improving as expected in H1 2025 · Persbericht

25/09 · Quest Diagnostics to Release Third Quarter 2025 Financial Results on October 21, 2025 · Persbericht

23/09 · Cegedim: DISCLOSURE OF SHARE CAPITAL AND VOTING RIGHTS · Persbericht

23/09 · Quest Diagnostics to Improve Laboratory Testing Experience with Industry-First Epic Collaboration · Persbericht

22/09 · Haystack Oncology and Rutgers Cancer Institute Collaborate in a Clinical Study to Examine Haystack MRD as a Guide for Post-Surgical Treatment for Lung Cancer · Persbericht

16/09 · Quest Diagnostics to Speak at the Jefferies Healthcare Services Conference · Persbericht

15/09 · Labcorp Completes Acquisition of Select Assets of BioReference Health's Innovative Oncology and Related Clinical Testing Services Businesses · Persbericht

Mijn selecties